COX10

Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0005739 mitochondrion	IBA GO_REF:0000033	ACCEPT	Summary: COX10 is a mitochondrial heme A biosynthesis enzyme. Reason: Correct broad localization.
GO:0006784 heme A biosynthetic process	IBA GO_REF:0000033	ACCEPT	Summary: COX10 catalyzes the heme O-forming step that is required for heme A biosynthesis. Reason: Core biological-process annotation. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md Heme A is produced by a two-step pathway in mitochondria: 1) COX10 (heme o synthase): heme b → heme o (prenylation), and 2) COX15 (heme a synthase): heme o → heme a
GO:0008495 protoheme IX farnesyltransferase activity	IBA GO_REF:0000033	ACCEPT	Summary: COX10 converts protoheme IX/heme b and farnesyl diphosphate to heme O. Reason: Core molecular-function annotation. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 catalyzes conversion of heme b (protoheme IX) to heme o by transferring a farnesyl moiety from farnesyl diphosphate to the vinyl group at C2 (pyrrole ring A) of heme b, producing heme o (a prenylated heme intermediate).
GO:0004659 prenyltransferase activity	IEA GO_REF:0000117	KEEP AS NON CORE	Summary: Prenyltransferase activity is a correct broad parent for COX10's protoheme IX farnesyltransferase activity. Reason: Keep as non-core because GO:0008495 is the specific core molecular function.
GO:0006783 heme biosynthetic process	IEA GO_REF:0000002	KEEP AS NON CORE	Summary: Heme biosynthetic process is a correct broad parent of heme A biosynthesis. Reason: Keep as non-core because GO:0006784 is the more precise process.
GO:0006784 heme A biosynthetic process	IEA GO_REF:0000117	ACCEPT	Summary: COX10 catalyzes the heme O-forming step that is required for heme A biosynthesis. Reason: Core biological-process annotation. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 catalyzes the first committed step of heme a biosynthesis, transferring a farnesyl group from farnesyl diphosphate to the vinyl group at C2 / pyrrole ring A of heme b (protoheme IX) to form heme o
GO:0008495 protoheme IX farnesyltransferase activity	IEA GO_REF:0000120	ACCEPT	Summary: COX10 converts protoheme IX/heme b and farnesyl diphosphate to heme O. Reason: Core molecular-function annotation. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 catalyzes conversion of heme b (protoheme IX) to heme o by transferring a farnesyl moiety from farnesyl diphosphate to the vinyl group at C2 (pyrrole ring A) of heme b, producing heme o (a prenylated heme intermediate).
GO:0016020 membrane	IEA GO_REF:0000002	KEEP AS NON CORE	Summary: COX10 is a membrane protein, but this cellular-component term is too general. Reason: Keep as non-core; mitochondrial inner/mitochondrial membrane terms are more informative.
GO:0016765 transferase activity, transferring alkyl or aryl (other than methyl) groups	IEA GO_REF:0000002	KEEP AS NON CORE	Summary: Transferase activity transferring alkyl or aryl groups is a broad parent description of the farnesyltransferase reaction. Reason: Keep as non-core because the specific GO:0008495 activity is present.
GO:0017004 cytochrome complex assembly	IEA GO_REF:0000117	KEEP AS NON CORE	Summary: COX10 deficiency disrupts cytochrome c oxidase assembly by limiting heme A availability. This is a consequence of its biosynthetic enzyme role rather than direct structural assembly-factor activity. Reason: Keep as non-core; heme A biosynthesis is the direct function. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, leading to complex IV deficiency
GO:0031966 mitochondrial membrane	IEA GO_REF:0000120	ACCEPT	Summary: COX10 is a mitochondrial membrane protein. Reason: Correct localization. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 is an integral mitochondrial inner membrane protein.
GO:0005739 mitochondrion	IEA GO_REF:0000107	ACCEPT	Summary: COX10 is a mitochondrial heme A biosynthesis enzyme. Reason: Correct broad localization.
GO:0005759 mitochondrial matrix	IEA GO_REF:0000107	MARK AS OVER ANNOTATED	Summary: COX10 is a multi-pass mitochondrial inner-membrane enzyme; the is_active_in matrix qualifier is potentially misleading if interpreted as a soluble matrix localization or as the main cellular-component context for the activity. Reason: Over-specific as an activity-location assertion for a membrane enzyme; mitochondrial inner membrane is the clearer location for COX10's protoheme IX farnesyltransferase activity.
GO:0005739 mitochondrion	IDA GO_REF:0000052	ACCEPT	Summary: COX10 is a mitochondrial heme A biosynthesis enzyme. Reason: Correct broad localization.
GO:0006783 heme biosynthetic process	TAS Reactome:R-HSA-189451	KEEP AS NON CORE	Summary: Heme biosynthetic process is a correct broad parent of heme A biosynthesis. Reason: Keep as non-core because GO:0006784 is the more precise process.
GO:0008495 protoheme IX farnesyltransferase activity	TAS Reactome:R-HSA-2995330	ACCEPT	Summary: COX10 converts protoheme IX/heme b and farnesyl diphosphate to heme O. Reason: Core molecular-function annotation. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 catalyzes conversion of heme b (protoheme IX) to heme o by transferring a farnesyl moiety from farnesyl diphosphate to the vinyl group at C2 (pyrrole ring A) of heme b, producing heme o (a prenylated heme intermediate).
GO:0005739 mitochondrion	HTP PMID:34800366 Quantitative high-confidence human mitochondrial proteome an...	ACCEPT	Summary: COX10 is a mitochondrial heme A biosynthesis enzyme. Reason: Correct broad localization. Supporting Evidence: file:human/COX10/COX10-uniprot.txt SUBCELLULAR LOCATION: Mitochondrion
GO:0004311 farnesyl-diphosphate farnesyltransferase activity	IGI PMID:8078902 Isolation of a human cDNA for heme A:farnesyltransferase by ...	REMOVE	Summary: GO:0004311 is now labeled farnesyl-diphosphate farnesyltransferase activity, but it is still not COX10's reaction. COX10 uses farnesyl diphosphate to farnesylate heme b/protoheme IX, forming heme O. Reason: Incorrect molecular-function assignment; keep protoheme IX farnesyltransferase activity (GO:0008495), which is already present, as the COX10-specific activity.
GO:0070069 cytochrome complex	IMP PMID:12928484 Mutations in COX10 result in a defect in mitochondrial heme ...	MARK AS OVER ANNOTATED	Summary: COX10 is required for Complex IV biogenesis, but it is a heme A biosynthesis enzyme and not a stable component of a cytochrome complex. Reason: Over-annotates a biosynthetic/assembly factor as if it were part of the respiratory cytochrome complex. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 is an integral mitochondrial inner membrane protein.
GO:0005743 mitochondrial inner membrane	TAS Reactome:R-HSA-2995330	ACCEPT	Summary: Reactome places the COX10 heme O-forming reaction at the mitochondrial inner membrane. Reason: Correct specific localization for the heme A biosynthesis enzyme. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 is an integral mitochondrial inner membrane protein.
GO:0005739 mitochondrion	IC PMID:14607829 Cytochrome c oxidase subassemblies in fibroblast cultures fr...	ACCEPT	Summary: COX10 is a mitochondrial heme A biosynthesis enzyme. Reason: Correct broad localization.
GO:0006784 heme A biosynthetic process	IMP PMID:12928484 Mutations in COX10 result in a defect in mitochondrial heme ...	ACCEPT	Summary: COX10 catalyzes the heme O-forming step that is required for heme A biosynthesis. Reason: Core biological-process annotation. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md COX10 catalyzes the first committed step of heme a biosynthesis, transferring a farnesyl group from farnesyl diphosphate to the vinyl group at C2 / pyrrole ring A of heme b (protoheme IX) to form heme o
GO:0008535 respiratory chain complex IV assembly	IMP PMID:14607829 Cytochrome c oxidase subassemblies in fibroblast cultures fr...	ACCEPT	Summary: COX10 mutations impair Complex IV assembly because heme A is required for assembly of the cytochrome c oxidase catalytic core. Reason: Correct downstream biological-process annotation supported by patient-cell assembly studies, while the direct molecular function remains heme O synthesis. Supporting Evidence: file:human/COX10/COX10-deep-research-falcon.md Heme A is uniquely used by cytochrome c oxidase (Complex IV) and is required not only for catalysis but also for proper maturation/stability of the catalytic core subunit COX1.
GO:0004311 farnesyl-diphosphate farnesyltransferase activity	TAS PMID:8078902 Isolation of a human cDNA for heme A:farnesyltransferase by ...	REMOVE	Summary: GO:0004311 is now labeled farnesyl-diphosphate farnesyltransferase activity, but it is still not COX10's reaction. COX10 uses farnesyl diphosphate to farnesylate heme b/protoheme IX, forming heme O. Reason: Incorrect molecular-function assignment; keep protoheme IX farnesyltransferase activity (GO:0008495), which is already present, as the COX10-specific activity.

Core Functions

COX10 is the mitochondrial protoheme IX farnesyltransferase/heme O synthase that catalyzes the first heme A biosynthetic step. By producing heme O as the precursor to heme A, COX10 is directly required for heme A biosynthesis and consequently for respiratory chain Complex IV assembly.

Molecular Function:

protoheme IX farnesyltransferase activity

Directly Involved In:

heme A biosynthetic process respiratory chain complex IV assembly

Cellular Locations:

mitochondrial inner membrane

Supporting Evidence:

PMID:12928484
COX10 functions in the first step of the mitochondrial heme A biosynthetic pathway, catalyzing the conversion of protoheme (heme B) to heme O
file:human/COX10/COX10-uniprot.txt
Converts protoheme IX and farnesyl diphosphate to heme O.
file:human/COX10/COX10-deep-research-falcon.md
**COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate).
file:human/COX10/COX10-deep-research-falcon.md
COX10 is an **integral mitochondrial inner membrane protein**.

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

InterPro2GO mapping infers GO terms (protoheme IX farnesyltransferase activity, heme A / heme O biosynthetic process, mitochondrial inner membrane) for COX10 from its conserved UbiA prenyltransferase / Cox10 domain signature.

GO_REF:0000033

Annotation inferences using phylogenetic trees

PAINT/PANTHER phylogenetic annotation transfers experimentally validated COX10 / heme O synthase functions across orthologs, supporting human COX10 annotation to protoheme IX farnesyltransferase activity and heme A biosynthetic process.

GO_REF:0000052

Gene Ontology annotation based on curation of immunofluorescence data

Curation of Human Protein Atlas immunofluorescence images supports COX10 mitochondrial localization at IDA evidence level.

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

Ensembl Compara orthology-based transfer propagates experimentally verified heme A biosynthesis / mitochondrial inner membrane annotations from COX10 orthologs to human COX10.

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

ARBA machine-learning rules predict GO terms (protoheme IX farnesyltransferase activity, heme A biosynthetic process, mitochondrial inner membrane) for COX10 from sequence and family features.

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

A combined automated pipeline integrating multiple IEA methods produces high-confidence IEA annotations of COX10 to the mitochondrial inner membrane and protoheme IX farnesyltransferase activity.

PMID:12928484

Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency.

Biallelic COX10 missense mutations cause isolated cytochrome c oxidase deficiency with a broad phenotypic spectrum (Leigh syndrome, hypertrophic cardiomyopathy, sensorineural deafness, anemia, tubulopathy / leukodystrophy), establishing COX10 as a major COX assembly disease gene.

"This study shows that mutations in this gene can cause nearly the full range of clinical phenotypes associated with early onset isolated COX deficiency."
COX10 catalyses the first step of the mitochondrial heme A biosynthetic pathway, converting protoheme (heme B) to heme O by farnesylation of the C2 vinyl group, and patient heme A content is reduced in proportion to residual COX enzyme activity.

"COX10 functions in the first step of the mitochondrial heme A biosynthetic pathway, catalyzing the conversion of protoheme (heme B) to heme O via the farnesylation of a vinyl group at position C2."
Retroviral re-expression of COX10 functionally complements patient fibroblast COX deficiency and reduced heme A content is rescued, providing direct cellular evidence that COX10 catalytic loss-of-function is the disease mechanism.

"expression of COX10 from a retroviral vector complements the COX deficiency in a patient with anemia and Leigh Syndrome, and in a patient with anemia, sensorineural deafness and fatal infantile hypertrophic cardiomyopathy."

PMID:14607829

Cytochrome c oxidase subassemblies in fibroblast cultures from patients carrying mutations in COX10, SCO1, or SURF1.

COX10-deficient fibroblasts accumulate early MTCO1-only Complex IV subassemblies and fail to form the MTCO1·COX4·COX5A intermediate, establishing that heme A incorporation into MTCO1 must occur before MTCO1 associates with COX4 and COX5A.

"The MTCO1.COX4.COX5A subassembly was not detected in COX10-deficient cells, which suggests that heme A incorporation into MTCO1 occurs prior to association of MTCO1 with COX4 and COX5A."
Comparison of COX10, SCO1 and SURF1 mutant fibroblasts maps three distinct stalling points of human CIV assembly, placing COX10-dependent MTCO1 hemylation upstream of Cu(A) installation (SCO1) and of MTCO2 incorporation (SURF1).

"SCO1-deficient cells contained accumulated levels of the MTCO1.COX4.COX5A subassembly, suggesting that MTCO2 associates with the MTCO1.COX4.COX5A subassembly after the Cu(A) center of MTCO2 is formed."

PMID:34800366

Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.

Quantitative mass-spectrometry-based mitochondrial proteomics confirms COX10 as a high-confidence mitochondrial protein and provides HTP evidence for its mitochondrion / inner membrane localization.

"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"

PMID:8078902

Isolation of a human cDNA for heme A:farnesyltransferase by functional complementation of a yeast cox10 mutant.

Cloned the human COX10 cDNA encoding a 443-aa heme A:farnesyltransferase by functional complementation of a yeast cox10-null mutant, providing the original molecular identification of human COX10.

"We have cloned the human homolog of the Saccharomyces cerevisiae COX10 gene by functional complementation of a yeast cox10 null mutant."
Demonstrates strong sequence and functional homology between human COX10 and the yeast and bacterial farnesyltransferases (heme O synthases), justifying transfer of yeast/bacterial Cox10 function to the human ortholog.

"The 2.8-kb cDNA encoding the human heme A:farnesyltransferase codes for a 443-aa protein with high homology to the yeast and bacterial farnesylases."

Reactome:R-HSA-189451

Heme biosynthesis

Reactome curates COX10 as a participant in the broad heme biosynthesis pathway; the more specific heme O / heme A biosynthetic-process annotations and COX10-specific Reactome reaction better capture its enzymatic role.

Reactome:R-HSA-2995330

COX10 transforms heme to heme O

Reactome's reaction "COX10 transforms heme to heme O" describes the COX10-catalysed first step of heme A biosynthesis at the mitochondrial inner membrane, supporting the protoheme IX farnesyltransferase activity (GO:0008495) annotation at TAS evidence level.

file:human/COX10/COX10-deep-research-falcon.md

Falcon deep research report on COX10

COX10 catalyzes the first committed step of heme A biosynthesis, transferring a farnesyl group from farnesyl diphosphate to the C2 vinyl group (pyrrole ring A) of heme b/protoheme IX to form heme O.

"**COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate)."
The proposed catalytic mechanism involves Mg2+-assisted ionization of farnesyl diphosphate, forming a farnesyl cation that is attacked by the heme vinyl group, with pyrophosphate release.

"the reaction is proposed to involve **Mg2+-assisted ionization of farnesyl diphosphate** to form a stabilized **farnesyl cation**, followed by **attack of the heme vinyl** to form the C–C bond; **pyrophosphate release** is implied by the diphosphate ionization step and the described donor chemistry."
Heme A biosynthesis is a two-step mitochondrial pathway: COX10 converts heme b to heme o, then COX15 converts heme o to heme a.

"Heme A is produced by a two-step pathway in mitochondria: 1) **COX10 (heme o synthase): heme b → heme o** (prenylation), and 2) **COX15 (heme a synthase): heme o → heme a**"
Heme A is used exclusively by cytochrome c oxidase (Complex IV) and is required for catalytic function as well as proper maturation/stability of the catalytic core subunit COX1.

"Heme A is uniquely used by **cytochrome c oxidase (Complex IV)** and is required not only for catalysis but also for proper maturation/stability of the catalytic core subunit **COX1**."
COX10 is an integral mitochondrial inner membrane protein.

"COX10 is an **integral mitochondrial inner membrane protein**."
COX10 is a ~46 kDa polytopic inner membrane enzyme with a predicted 8-9 transmembrane helices and a matrix-facing catalytic site; it assembles into homo-oligomeric complexes of ~300 kDa.

"- **~46 kDa**, evolutionarily conserved, - predicted **8–9 transmembrane helices**, with the **catalytic site facing the matrix**, and - assembling into **homo-oligomeric complexes (~300 kDa)**."
Human COX10 is associated with COX15 and copper/metallochaperone factors (COX11, SCO1, SCO2, COA3, COX16, PET191, COX19) and was detected in the SURF1 interactome, integrating heme A biosynthesis with Complex IV assembly.

"human COX10 is trapped together with COX15 and multiple copper/metallochaperone factors (e.g., COX11, SCO1/2, COA3, COX16, PET191, COX19), linking heme A biosynthesis with copper delivery modules and early assembly intermediates. COX10 silencing impacted levels of PET191/COX19 and impaired formation of early metallochaperone complexes, supporting a systems-level role in complex IV biogenesis beyond a standalone enzymatic step."
COX10 oligomerization depends on newly synthesized COX1 and early COX1 assembly intermediates, coupling heme A production to the assembly state of Complex IV.

"mitochondrial heme reviews describe COX10 oligomerization as depending on newly synthesized **COX1** and early COX1 assembly intermediates, consistent with heme A production being tuned to the assembly state of complex IV."
Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, causing Complex IV deficiency and Leigh(-like) syndromes.

"Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, leading to **complex IV deficiency**; COX10 mutations are repeatedly discussed as causes of severe mitochondrial disease presentations including **Leigh(-like) syndromes** and other complex IV deficiency phenotypes."
COX10 belongs to the UbiA intramembrane aromatic prenyltransferase family. Orthology between human COX10 and yeast Cox10 was established by functional complementation.

"Human **COX10** (UniProt **Q12887**) corresponds to **protoheme IX farnesyltransferase, mitochondrial**, also called **heme O synthase**; it belongs to the **UbiA intramembrane aromatic prenyltransferase family** that catalyzes membrane-embedded prenyl transfer reactions. Orthology between human COX10 and yeast Cox10 was established by functional complementation."
A 2024 yeast complementation assay of 25 human COX10 variants found 11/25 supported ~50% or more of reference cytochrome c oxidase activity; ClinVar had 102 COX10 variants as of Jun 2024, with ~75% classified as variants of uncertain significance.

"**ClinVar listed 102 COX10 variants** as of **17 Jun 2024**, with **nearly three-quarters** categorized as **variants of uncertain significance (VUS)**. (voges2024phenotypicassessmentof pages 1-2) - The authors tested **25 human COX10 variants**; **11/25** supported **~50% or more** of reference cytochrome c oxidase activity and also grew robustly on nonfermentable medium."
A small assembly factor COA2 stabilizes the COX10 complex; COX10 and COX15 function together for heme A synthesis.

"COX10 and COX15 are described as interacting/working together for heme A synthesis, and a small assembly factor **COA2** is described as stabilizing the COX10 complex."

Suggested Experiments

Experiment: Apply native MS / crosslinking-MS to immunopurified COX10 and COX15 complexes from human cells; complement with proximity labeling (BioID/TurboID) of active vs catalytically inactive COX10 and COX15 to map the heme-channeling interface; quantify free heme O / heme A pools by LC-MS in the same cells.

Hypothesis: COX10 and COX15 form an obligate heme A synthesis super-complex with COX1 that channels heme O between active sites.

Type: native MS and proximity labeling of heme A biosynthetic complexes

Experiment: Use puromycin-pulse, doxycycline-controlled MT-CO1 translation, and COA3/COX14 depletion in human cells; track COX10 oligomeric state (BN-PAGE, sucrose gradients) and turnover (cycloheximide chase / SILAC).

Hypothesis: COX10 oligomerization is gated by newly synthesized MT-CO1; uncoupling MT-CO1 translation from heme O production triggers COX10 disassembly and degradation.

Type: translational coupling and oligomer dynamics assay

Experiment: Reconstitute recombinant COX10 variants in liposomes / nanodiscs and measure protoheme IX farnesyltransferase kinetics; compare against complementation rescue of COX10-null human cells (CIV activity, BN-PAGE, mitochondrial respirometry) for the same panel of variants.

Hypothesis: A subset of ClinVar VUS COX10 alleles are separation-of-function variants that preserve farnesyltransferase activity in vitro but fail to support CIV assembly in vivo.

Type: paired in-vitro enzymology and human-cell complementation of ClinVar VUS

Deep Research

Falcon

(COX10-deep-research-falcon.md)

this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 27 citations 2 artifacts 2026-05-29T23:17:11.007311

Edison artifact artifact-00 (text/markdown)

## Context ID: pqac-00000016 I have extracted Table 1, which lists known pathological variants of human COX10, and Figure 1, which summarizes the growth phenoty (image/png)

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Human COX10 (UniProt Q12887) – functional annotation

0) Mandatory target verification (gene/protein identity)

The UniProt accession Q12887 corresponds to human COX10, annotated as protoheme IX farnesyltransferase, mitochondrial (also called heme O synthase), a UbiA-family intramembrane prenyltransferase required for heme A production used by cytochrome c oxidase (Complex IV). This identity matches the literature describing “heme O synthase/COX10” as the enzyme that attaches a farnesyl tail to protoheme IX (heme b), the first step of heme A synthesis. (li2016bringingbioactivecompounds pages 9-11, guaragnella2024morethanjust pages 7-8)

1) Key concepts and definitions (current understanding)

1.1 COX10 biochemical function (reaction, substrates, products)

COX10 catalyzes conversion of heme b (protoheme IX) to heme o by transferring a farnesyl moiety from farnesyl diphosphate to the vinyl group at C2 (pyrrole ring A) of heme b, producing heme o (a prenylated heme intermediate). (ali2025mechanismsofheme pages 2-3, rivett2021biosynthesisandtrafficking pages 34-38)

Mechanistic understanding from structural/biochemical synthesis reviews: the reaction is proposed to involve Mg2+-assisted ionization of farnesyl diphosphate to form a stabilized farnesyl cation, followed by attack of the heme vinyl to form the C–C bond; pyrophosphate release is implied by the diphosphate ionization step and the described donor chemistry. The precise ordering of donor ionization, condensation, and hydroxyl incorporation into the final hydroxyethylfarnesyl substituent remains unresolved. (rivett2021biosynthesisandtrafficking pages 34-38)

Substrate specificity (current consensus): COX10/HOS uses heme b as the prenyl acceptor and farnesyl diphosphate as prenyl donor; some organisms can incorporate alternative prenyl chains (e.g., C15/C20 variants) but the canonical mitochondrial pathway uses the farnesyl donor. (rivett2021biosynthesisandtrafficking pages 34-38)

1.2 Pathway context: heme A biosynthesis and Complex IV biogenesis

Heme A is produced by a two-step pathway in mitochondria:
1) COX10 (heme o synthase): heme b → heme o (prenylation), and
2) COX15 (heme a synthase): heme o → heme a (oxidation of the pyrrole ring D methyl at C8 to an aldehyde). (ali2025mechanismsofheme pages 2-3, ali2025mechanismsofheme pages 3-4)

Heme A is uniquely used by cytochrome c oxidase (Complex IV) and is required not only for catalysis but also for proper maturation/stability of the catalytic core subunit COX1. (li2016bringingbioactivecompounds pages 9-11, swenson2020fromsynthesisto pages 8-10)

A recurring current concept is that heme A biosynthesis is integrated into the COX1 assembly line rather than occurring as a fully independent metabolic module; for example, early COX1 assembly intermediates influence COX10 organization (see below). (swenson2020fromsynthesisto pages 10-12)

2) Cellular localization, membrane topology, and molecular organization

2.1 Subcellular compartment

COX10 is an integral mitochondrial inner membrane protein. (voges2024phenotypicassessmentof pages 1-2, guaragnella2024morethanjust pages 7-8)

2.2 Topology and oligomeric state (best current model)

Because COX10 is a hydrophobic, polytopic membrane enzyme, detailed experimental topology in humans remains limited in the cited sources; however, widely cited mitochondrial heme reviews describe COX10 as:
- ~46 kDa, evolutionarily conserved,
- predicted 8–9 transmembrane helices, with the catalytic site facing the matrix, and
- assembling into homo-oligomeric complexes (~300 kDa). (swenson2020fromsynthesisto pages 10-12)

This organization is functionally relevant because COX10 multimerization is influenced by the status of early complex IV assembly intermediates (below). (swenson2020fromsynthesisto pages 10-12)

3) Recent developments and latest research (prioritized 2023–2024)

3.1 Integration with Complex IV assembly modules (2023 review synthesis)

A 2023 FEBS Letters review on COX1 translation/early assembly highlights that proteins involved in metal center and cofactor insertion connect to the COX1 assembly machinery, and reports COX10 grouping with other metallo-chaperones (including COX15/COX11) and being detected in the SURF1 interactome, consistent with coordination between heme A synthesis and COX1 maturation. Publication date: May 2023. URL: https://doi.org/10.1002/1873-3468.14671 (dennerlein2023cytochromecoxidase pages 6-7)

3.2 Functional interpretation of human COX10 variants at scale (2024)

A 2024 BMC Research Notes study directly addresses a major translational bottleneck—classification of newly observed COX10 alleles—by expressing human COX10 variants in a yeast Cox10-null system and measuring respiratory growth and COX activity. Publication date: Aug 2024. URL: https://doi.org/10.1186/s13104-024-06879-5 (voges2024phenotypicassessmentof pages 1-2, voges2024phenotypicassessmentof pages 2-4)

Key quantitative outcomes (2024):
- ClinVar listed 102 COX10 variants as of 17 Jun 2024, with nearly three-quarters categorized as variants of uncertain significance (VUS). (voges2024phenotypicassessmentof pages 1-2)
- The authors tested 25 human COX10 variants; 11/25 supported ~50% or more of reference cytochrome c oxidase activity and also grew robustly on nonfermentable medium. (voges2024phenotypicassessmentof pages 1-2)
- Several “uncertain significance” alleles were functional (e.g., S103A, D152Y, A174T, F209L, C343R, V356M) and several were nonfunctional (e.g., I127T, D132Y), illustrating that clinical annotation can disagree with functional phenotype. (voges2024phenotypicassessmentof pages 2-4)

The table/figure summaries from this paper are available as extracted visuals (Table 1 and Figure 1). (voges2024phenotypicassessmentof media d9125d2f, voges2024phenotypicassessmentof media 7a41da9d)

3.3 Yeast as an expert-endorsed platform for COX deficiency variant interpretation (2024 review)

A 2024 International Journal of Molecular Sciences review emphasizes that yeast genetics has historically enabled identification of COX assembly genes and is still valuable for testing pathogenicity of patient variants, citing COX10 among heme A biosynthetic factors where functional complementation can establish orthology and variant effects. Publication date: Mar 2024. URL: https://doi.org/10.3390/ijms25073814 (guaragnella2024morethanjust pages 7-8)

4) Functional role in protein networks: interaction partners and assembly logic

4.1 COX10–COX15 functional coupling and stabilization

COX10 and COX15 are described as interacting/working together for heme A synthesis, and a small assembly factor COA2 is described as stabilizing the COX10 complex. (guaragnella2024morethanjust pages 7-8)

More broadly, mitochondrial heme reviews describe COX10 oligomerization as depending on newly synthesized COX1 and early COX1 assembly intermediates, consistent with heme A production being tuned to the assembly state of complex IV. (swenson2020fromsynthesisto pages 10-12)

4.2 Human cell evidence for association with metallochaperone assemblies (authoritative primary research)

A high-impact human cell study (Nature Communications; publication date Jun 2022; URL: https://doi.org/10.1038/s41467-022-31413-1) reports that human COX10 is trapped together with COX15 and multiple copper/metallochaperone factors (e.g., COX11, SCO1/2, COA3, COX16, PET191, COX19), linking heme A biosynthesis with copper delivery modules and early assembly intermediates. COX10 silencing impacted levels of PET191/COX19 and impaired formation of early metallochaperone complexes, supporting a systems-level role in complex IV biogenesis beyond a standalone enzymatic step. (nyvltova2022coordinationofmetal pages 8-9)

5) Disease relevance, applications, and real-world implementations

5.1 Disease mechanism (mitochondrial respiratory chain / Leigh spectrum)

Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, leading to complex IV deficiency; COX10 mutations are repeatedly discussed as causes of severe mitochondrial disease presentations including Leigh(-like) syndromes and other complex IV deficiency phenotypes. (voges2024phenotypicassessmentof pages 1-2, guaragnella2024morethanjust pages 7-8)

5.2 Current applications

A) Clinical variant interpretation and functional genomics
The 2024 yeast expression/phenotyping pipeline is a directly deployable functional genomics approach for clarifying whether a COX10 variant is likely to be loss-of-function, addressing the high fraction of ClinVar VUS in COX10. (voges2024phenotypicassessmentof pages 1-2, voges2024phenotypicassessmentof pages 2-4)

B) Mechanistic assignment of pathogenicity using model systems
The 2024 review of yeast approaches frames Saccharomyces cerevisiae as a practical platform to: (i) demonstrate gene orthology, (ii) test the functional consequence of patient variants, and (iii) connect variant effects to specific steps in complex IV assembly (including heme A synthesis via COX10/COX15). (guaragnella2024morethanjust pages 7-8)

6) Data-driven summary (selected statistics and experimentally grounded statements)

Topic	Current understanding	Key sources
Identity / names / family	Human COX10 (UniProt Q12887) corresponds to protoheme IX farnesyltransferase, mitochondrial, also called heme O synthase; it belongs to the UbiA intramembrane aromatic prenyltransferase family that catalyzes membrane-embedded prenyl transfer reactions. Orthology between human COX10 and yeast Cox10 was established by functional complementation. (guaragnella2024morethanjust pages 7-8, li2016bringingbioactivecompounds pages 9-11)	(guaragnella2024morethanjust pages 7-8, li2016bringingbioactivecompounds pages 9-11)
Enzymatic reaction	COX10 catalyzes the first committed step of heme a biosynthesis, transferring a farnesyl group from farnesyl diphosphate to the vinyl group at C2 / pyrrole ring A of heme b (protoheme IX) to form heme o; pyrophosphate release is mechanistically implied by donor ionization and Mg2+-assisted departure. This converts the C2 vinyl into a hydroxyethylfarnesyl substituent. (ali2025mechanismsofheme pages 2-3, rivett2021biosynthesisandtrafficking pages 34-38, swenson2020fromsynthesisto pages 8-10, rivett2021biosynthesisandtrafficking pages 7-9)	(ali2025mechanismsofheme pages 2-3, rivett2021biosynthesisandtrafficking pages 34-38, swenson2020fromsynthesisto pages 8-10, rivett2021biosynthesisandtrafficking pages 7-9)
Subcellular localization / topology	COX10 is an integral mitochondrial inner membrane protein; reviews describe it as a large polytopic membrane enzyme with predicted ~8–9 transmembrane helices and a matrix-facing catalytic site. It can assemble into homo-oligomeric complexes of ~300 kDa. (voges2024phenotypicassessmentof pages 1-2, swenson2020fromsynthesisto pages 10-12, ali2025mechanismsofheme pages 3-4)	(voges2024phenotypicassessmentof pages 1-2, swenson2020fromsynthesisto pages 10-12, ali2025mechanismsofheme pages 3-4)
Pathway role	COX10 acts upstream of COX15 in the two-step pathway heme b → heme o → heme a. Heme a is then incorporated into COX1 / cytochrome c oxidase (complex IV), where it is essential for core subunit folding, maturation, and catalytic function. COX10 abundance appears limiting relative to COX15, suggesting COX10 may be rate-limiting for heme a production in some settings. (guaragnella2024morethanjust pages 7-8, ali2025mechanismsofheme pages 3-4, swenson2020fromsynthesisto pages 10-12)	(guaragnella2024morethanjust pages 7-8, ali2025mechanismsofheme pages 3-4, swenson2020fromsynthesisto pages 10-12)
Key interactions / assembly modules	COX10 function is linked to COX15, COA2, and COX1 assembly intermediates. Human studies place COX10 in complexes with COX15 and copper/metallochaperone factors including COX11, SCO1, SCO2, COA3, COX16, PET191, and COX19; COX10 was also detected in the SURF1 interactome, supporting integration of heme a biosynthesis with complex IV assembly. (guaragnella2024morethanjust pages 7-8, nyvltova2022coordinationofmetal pages 8-9, ali2025mechanismsofheme pages 3-4, dennerlein2023cytochromecoxidase pages 6-7)	(guaragnella2024morethanjust pages 7-8, nyvltova2022coordinationofmetal pages 8-9, ali2025mechanismsofheme pages 3-4, dennerlein2023cytochromecoxidase pages 6-7)
2024 functional variant data	A 2024 yeast complementation study reported that ClinVar listed 102 COX10 variants as of 17 Jun 2024, with nearly three-quarters classified as uncertain significance. The authors tested 25 human variants; 11/25 retained ~50% or more of reference COX activity and supported respiratory growth. Examples classified as functional in that assay included S103A, P104L, A328T, R431W, S103A, D152Y, A174T, F209L, C343R, V356M; examples with poor/nonfunctional behavior included T87I, I127T, D132Y, D336V, R339W. Variants with ~50% activity supported glycerol growth, whereas variants with <25% activity generally failed to grow on nonfermentable medium. (voges2024phenotypicassessmentof pages 1-2, voges2024phenotypicassessmentof pages 2-4)	(voges2024phenotypicassessmentof pages 1-2, voges2024phenotypicassessmentof pages 2-4)

Table: This table condenses the main functional annotation points for human COX10, including identity, catalytic reaction, mitochondrial localization, pathway role in heme a and complex IV biogenesis, interaction partners, and the most relevant 2024 human variant assay statistics.

Additionally, the extracted figure/table images summarizing variant growth and COX activity in Voges et al. 2024 can be used as primary visual evidence of allele-specific functional outcomes. (voges2024phenotypicassessmentof media d9125d2f, voges2024phenotypicassessmentof media 7a41da9d)

7) Limitations and open questions (expert synthesis)

Even with improved structural modeling and interaction mapping, multiple mechanistic questions remain unresolved in authoritative reviews:
- how heme b is physically transferred from ferrochelatase (FECH) to COX10’s membrane-embedded active site, and
- whether/how heme o is directly handed off to COX15 versus trafficked through other intermediates. (ali2025mechanismsofheme pages 2-3, swenson2020fromsynthesisto pages 10-12, ali2025mechanismsofheme pages 3-4)

These open points are important for interpreting why some partial-loss COX10 variants may produce heterogeneous clinical phenotypes and for identifying potential therapeutic leverage points (e.g., stabilizing assembly intermediates vs. altering cofactor flux). (guaragnella2024morethanjust pages 7-8, nyvltova2022coordinationofmetal pages 8-9)

Key URLs (most relevant; with publication month/year)

Dennerlein et al., May 2023, FEBS Letters: https://doi.org/10.1002/1873-3468.14671 (dennerlein2023cytochromecoxidase pages 6-7)
Guaragnella et al., Mar 2024, IJMS: https://doi.org/10.3390/ijms25073814 (guaragnella2024morethanjust pages 7-8)
Voges et al., Aug 2024, BMC Research Notes: https://doi.org/10.1186/s13104-024-06879-5 (voges2024phenotypicassessmentof pages 1-2)
Nývltová et al., Jun 2022, Nat Commun: https://doi.org/10.1038/s41467-022-31413-1 (nyvltova2022coordinationofmetal pages 8-9)
Rivett et al., Aug 2021, Crit Rev Biochem Mol Biol: https://doi.org/10.1080/10409238.2021.1957668 (rivett2021biosynthesisandtrafficking pages 34-38)
Swenson et al., Feb 2020, Cells: https://doi.org/10.3390/cells9030579 (swenson2020fromsynthesisto pages 10-12)
Li, Apr 2016, Trends Biochem Sci: https://doi.org/10.1016/j.tibs.2016.01.007 (li2016bringingbioactivecompounds pages 9-11)

References

(li2016bringingbioactivecompounds pages 9-11): Weikai Li. Bringing bioactive compounds into membranes: the ubia superfamily of intramembrane aromatic prenyltransferases. Trends in biochemical sciences, 41 4:356-370, Apr 2016. URL: https://doi.org/10.1016/j.tibs.2016.01.007, doi:10.1016/j.tibs.2016.01.007. This article has 131 citations and is from a domain leading peer-reviewed journal.
(guaragnella2024morethanjust pages 7-8): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations.
(ali2025mechanismsofheme pages 2-3): Saieeda Fabia Ali, Adrianna E. White, Amy Medlock, and Oleh Khalimonchuk. Mechanisms of heme transport in the mitochondria. Biochemical Society Transactions, 53:603-614, May 2025. URL: https://doi.org/10.1042/bst20253013, doi:10.1042/bst20253013. This article has 3 citations and is from a peer-reviewed journal.
(rivett2021biosynthesisandtrafficking pages 34-38): Elise D. Rivett, Lim Heo, Michael Feig, and Eric L. Hegg. Biosynthesis and trafficking of heme o and heme a: new structural insights and their implications for reaction mechanisms and prenylated heme transfer. Critical Reviews in Biochemistry and Molecular Biology, 56:640-668, Aug 2021. URL: https://doi.org/10.1080/10409238.2021.1957668, doi:10.1080/10409238.2021.1957668. This article has 23 citations and is from a peer-reviewed journal.
(ali2025mechanismsofheme pages 3-4): Saieeda Fabia Ali, Adrianna E. White, Amy Medlock, and Oleh Khalimonchuk. Mechanisms of heme transport in the mitochondria. Biochemical Society Transactions, 53:603-614, May 2025. URL: https://doi.org/10.1042/bst20253013, doi:10.1042/bst20253013. This article has 3 citations and is from a peer-reviewed journal.
(swenson2020fromsynthesisto pages 8-10): Samantha A. Swenson, Courtney M. Moore, Jason R. Marcero, Amy E. Medlock, Amit R. Reddi, and Oleh Khalimonchuk. From synthesis to utilization: the ins and outs of mitochondrial heme. Cells, 9:579, Feb 2020. URL: https://doi.org/10.3390/cells9030579, doi:10.3390/cells9030579. This article has 177 citations.
(swenson2020fromsynthesisto pages 10-12): Samantha A. Swenson, Courtney M. Moore, Jason R. Marcero, Amy E. Medlock, Amit R. Reddi, and Oleh Khalimonchuk. From synthesis to utilization: the ins and outs of mitochondrial heme. Cells, 9:579, Feb 2020. URL: https://doi.org/10.3390/cells9030579, doi:10.3390/cells9030579. This article has 177 citations.
(voges2024phenotypicassessmentof pages 1-2): Thomas-Shadi Voges, Eun Bi Lim, Abigail MacKenzie, Kyle Mudler, Rebecca DeSouza, Nmesoma E. Onyejekwe, and Stephen D. Johnston. Phenotypic assessment of cox10 variants and their implications for leigh syndrome. BMC Research Notes, Aug 2024. URL: https://doi.org/10.1186/s13104-024-06879-5, doi:10.1186/s13104-024-06879-5. This article has 1 citations and is from a peer-reviewed journal.
(dennerlein2023cytochromecoxidase pages 6-7): Sven Dennerlein, Peter Rehling, and Ricarda Richter‐Dennerlein. Cytochrome c oxidase biogenesis – from translation to early assembly of the core subunit cox1. FEBS Letters, 597:1569-1578, May 2023. URL: https://doi.org/10.1002/1873-3468.14671, doi:10.1002/1873-3468.14671. This article has 31 citations and is from a peer-reviewed journal.
(voges2024phenotypicassessmentof pages 2-4): Thomas-Shadi Voges, Eun Bi Lim, Abigail MacKenzie, Kyle Mudler, Rebecca DeSouza, Nmesoma E. Onyejekwe, and Stephen D. Johnston. Phenotypic assessment of cox10 variants and their implications for leigh syndrome. BMC Research Notes, Aug 2024. URL: https://doi.org/10.1186/s13104-024-06879-5, doi:10.1186/s13104-024-06879-5. This article has 1 citations and is from a peer-reviewed journal.
(voges2024phenotypicassessmentof media d9125d2f): Thomas-Shadi Voges, Eun Bi Lim, Abigail MacKenzie, Kyle Mudler, Rebecca DeSouza, Nmesoma E. Onyejekwe, and Stephen D. Johnston. Phenotypic assessment of cox10 variants and their implications for leigh syndrome. BMC Research Notes, Aug 2024. URL: https://doi.org/10.1186/s13104-024-06879-5, doi:10.1186/s13104-024-06879-5. This article has 1 citations and is from a peer-reviewed journal.
(voges2024phenotypicassessmentof media 7a41da9d): Thomas-Shadi Voges, Eun Bi Lim, Abigail MacKenzie, Kyle Mudler, Rebecca DeSouza, Nmesoma E. Onyejekwe, and Stephen D. Johnston. Phenotypic assessment of cox10 variants and their implications for leigh syndrome. BMC Research Notes, Aug 2024. URL: https://doi.org/10.1186/s13104-024-06879-5, doi:10.1186/s13104-024-06879-5. This article has 1 citations and is from a peer-reviewed journal.
(nyvltova2022coordinationofmetal pages 8-9): Eva Nývltová, Jonathan V. Dietz, Javier Seravalli, Oleh Khalimonchuk, and Antoni Barrientos. Coordination of metal center biogenesis in human cytochrome c oxidase. Nature Communications, Jun 2022. URL: https://doi.org/10.1038/s41467-022-31413-1, doi:10.1038/s41467-022-31413-1. This article has 109 citations and is from a highest quality peer-reviewed journal.
(rivett2021biosynthesisandtrafficking pages 7-9): Elise D. Rivett, Lim Heo, Michael Feig, and Eric L. Hegg. Biosynthesis and trafficking of heme o and heme a: new structural insights and their implications for reaction mechanisms and prenylated heme transfer. Critical Reviews in Biochemistry and Molecular Biology, 56:640-668, Aug 2021. URL: https://doi.org/10.1080/10409238.2021.1957668, doi:10.1080/10409238.2021.1957668. This article has 23 citations and is from a peer-reviewed journal.

Artifacts

Edison artifact artifact-00

Citations

rivett2021biosynthesisandtrafficking pages 34-38
swenson2020fromsynthesisto pages 10-12
dennerlein2023cytochromecoxidase pages 6-7
voges2024phenotypicassessmentof pages 1-2
voges2024phenotypicassessmentof pages 2-4
guaragnella2024morethanjust pages 7-8
nyvltova2022coordinationofmetal pages 8-9
li2016bringingbioactivecompounds pages 9-11
ali2025mechanismsofheme pages 2-3
ali2025mechanismsofheme pages 3-4
swenson2020fromsynthesisto pages 8-10
rivett2021biosynthesisandtrafficking pages 7-9
https://doi.org/10.1002/1873-3468.14671
https://doi.org/10.1186/s13104-024-06879-5
https://doi.org/10.3390/ijms25073814
https://doi.org/10.1038/s41467-022-31413-1
https://doi.org/10.1080/10409238.2021.1957668
https://doi.org/10.3390/cells9030579
https://doi.org/10.1016/j.tibs.2016.01.007
https://doi.org/10.1016/j.tibs.2016.01.007,
https://doi.org/10.3390/ijms25073814,
https://doi.org/10.1042/bst20253013,
https://doi.org/10.1080/10409238.2021.1957668,
https://doi.org/10.3390/cells9030579,
https://doi.org/10.1186/s13104-024-06879-5,
https://doi.org/10.1002/1873-3468.14671,
https://doi.org/10.1038/s41467-022-31413-1,

📄 View Raw YAML

id: Q12887
gene_symbol: COX10
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  COX10 is a multi-pass mitochondrial membrane enzyme required for heme A biosynthesis and Complex
  IV biogenesis. It catalyzes the first committed heme A pathway reaction, converting protoheme IX/heme
  b and farnesyl diphosphate to heme O. COX10 is therefore a heme O synthase/protoheme IX farnesyltransferase,
  not a stable structural subunit of cytochrome c oxidase. Loss of COX10 impairs heme A production,
  blocks early Complex IV assembly, and causes mitochondrial Complex IV deficiency, nuclear type 3.
alternative_products:
  - name: '1'
    id: Q12887-1
  - name: '2'
    id: Q12887-2
    sequence_note: VSP_056867, VSP_056868
existing_annotations:
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    qualifier: is_active_in
    review:
      summary: >-
        COX10 is a mitochondrial heme A biosynthesis enzyme.
      action: ACCEPT
      reason: >-
        Correct broad localization.
  - term:
      id: GO:0006784
      label: heme A biosynthetic process
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    qualifier: involved_in
    review:
      summary: >-
        COX10 catalyzes the heme O-forming step that is required for heme A biosynthesis.
      action: ACCEPT
      reason: >-
        Core biological-process annotation.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            Heme A is produced by a two-step pathway in mitochondria:
            1) **COX10 (heme o synthase): heme b → heme o** (prenylation), and
            2) **COX15 (heme a synthase): heme o → heme a**
  - term:
      id: GO:0008495
      label: protoheme IX farnesyltransferase activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    qualifier: enables
    review:
      summary: >-
        COX10 converts protoheme IX/heme b and farnesyl diphosphate to heme O.
      action: ACCEPT
      reason: >-
        Core molecular-function annotation.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            **COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate).
  - term:
      id: GO:0004659
      label: prenyltransferase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    qualifier: enables
    review:
      summary: >-
        Prenyltransferase activity is a correct broad parent for COX10's protoheme IX farnesyltransferase
        activity.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core because GO:0008495 is the specific core molecular function.
  - term:
      id: GO:0006783
      label: heme biosynthetic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: involved_in
    review:
      summary: >-
        Heme biosynthetic process is a correct broad parent of heme A biosynthesis.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core because GO:0006784 is the more precise process.
  - term:
      id: GO:0006784
      label: heme A biosynthetic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    qualifier: involved_in
    review:
      summary: >-
        COX10 catalyzes the heme O-forming step that is required for heme A biosynthesis.
      action: ACCEPT
      reason: >-
        Core biological-process annotation.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            COX10 catalyzes the **first committed step of heme a biosynthesis**, transferring a **farnesyl group from farnesyl diphosphate** to the **vinyl group at C2 / pyrrole ring A of heme b (protoheme IX)** to form **heme o**
  - term:
      id: GO:0008495
      label: protoheme IX farnesyltransferase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    qualifier: enables
    review:
      summary: >-
        COX10 converts protoheme IX/heme b and farnesyl diphosphate to heme O.
      action: ACCEPT
      reason: >-
        Core molecular-function annotation.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            **COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate).
  - term:
      id: GO:0016020
      label: membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: located_in
    review:
      summary: >-
        COX10 is a membrane protein, but this cellular-component term is too general.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core; mitochondrial inner/mitochondrial membrane terms are more informative.
  - term:
      id: GO:0016765
      label: transferase activity, transferring alkyl or aryl (other than methyl) groups
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    qualifier: enables
    review:
      summary: >-
        Transferase activity transferring alkyl or aryl groups is a broad parent description of the
        farnesyltransferase reaction.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core because the specific GO:0008495 activity is present.
  - term:
      id: GO:0017004
      label: cytochrome complex assembly
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    qualifier: involved_in
    review:
      summary: >-
        COX10 deficiency disrupts cytochrome c oxidase assembly by limiting heme A availability. This
        is a consequence of its biosynthetic enzyme role rather than direct structural assembly-factor
        activity.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core; heme A biosynthesis is the direct function.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, leading to **complex IV deficiency**
  - term:
      id: GO:0031966
      label: mitochondrial membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    qualifier: located_in
    review:
      summary: >-
        COX10 is a mitochondrial membrane protein.
      action: ACCEPT
      reason: >-
        Correct localization.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            COX10 is an **integral mitochondrial inner membrane protein**.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    qualifier: located_in
    review:
      summary: >-
        COX10 is a mitochondrial heme A biosynthesis enzyme.
      action: ACCEPT
      reason: >-
        Correct broad localization.
  - term:
      id: GO:0005759
      label: mitochondrial matrix
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    qualifier: is_active_in
    review:
      summary: >-
        COX10 is a multi-pass mitochondrial inner-membrane enzyme; the is_active_in matrix qualifier
        is potentially misleading if interpreted as a soluble matrix localization or as the main
        cellular-component context for the activity.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Over-specific as an activity-location assertion for a membrane enzyme; mitochondrial inner
        membrane is the clearer location for COX10's protoheme IX farnesyltransferase activity.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IDA
    original_reference_id: GO_REF:0000052
    qualifier: located_in
    review:
      summary: >-
        COX10 is a mitochondrial heme A biosynthesis enzyme.
      action: ACCEPT
      reason: >-
        Correct broad localization.
  - term:
      id: GO:0006783
      label: heme biosynthetic process
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-189451
    qualifier: involved_in
    review:
      summary: >-
        Heme biosynthetic process is a correct broad parent of heme A biosynthesis.
      action: KEEP_AS_NON_CORE
      reason: >-
        Keep as non-core because GO:0006784 is the more precise process.
  - term:
      id: GO:0008495
      label: protoheme IX farnesyltransferase activity
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-2995330
    qualifier: enables
    review:
      summary: >-
        COX10 converts protoheme IX/heme b and farnesyl diphosphate to heme O.
      action: ACCEPT
      reason: >-
        Core molecular-function annotation.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            **COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate).
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: HTP
    original_reference_id: PMID:34800366
    qualifier: located_in
    review:
      summary: >-
        COX10 is a mitochondrial heme A biosynthesis enzyme.
      action: ACCEPT
      reason: >-
        Correct broad localization.
      supported_by:
        - reference_id: file:human/COX10/COX10-uniprot.txt
          supporting_text: >-
            SUBCELLULAR LOCATION: Mitochondrion
  - term:
      id: GO:0004311
      label: farnesyl-diphosphate farnesyltransferase activity
    evidence_type: IGI
    original_reference_id: PMID:8078902
    qualifier: enables
    review:
      summary: >-
        GO:0004311 is now labeled farnesyl-diphosphate farnesyltransferase activity, but it is
        still not COX10's reaction. COX10 uses farnesyl diphosphate to farnesylate heme
        b/protoheme IX, forming heme O.
      action: REMOVE
      reason: >-
        Incorrect molecular-function assignment; keep protoheme IX farnesyltransferase activity
        (GO:0008495), which is already present, as the COX10-specific activity.
  - term:
      id: GO:0070069
      label: cytochrome complex
    evidence_type: IMP
    original_reference_id: PMID:12928484
    qualifier: part_of
    review:
      summary: >-
        COX10 is required for Complex IV biogenesis, but it is a heme A biosynthesis enzyme and not
        a stable component of a cytochrome complex.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Over-annotates a biosynthetic/assembly factor as if it were part of the respiratory cytochrome
        complex.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            COX10 is an **integral mitochondrial inner membrane protein**.
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-2995330
    qualifier: located_in
    review:
      summary: >-
        Reactome places the COX10 heme O-forming reaction at the mitochondrial inner membrane.
      action: ACCEPT
      reason: >-
        Correct specific localization for the heme A biosynthesis enzyme.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            COX10 is an **integral mitochondrial inner membrane protein**.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IC
    original_reference_id: PMID:14607829
    qualifier: located_in
    review:
      summary: >-
        COX10 is a mitochondrial heme A biosynthesis enzyme.
      action: ACCEPT
      reason: >-
        Correct broad localization.
  - term:
      id: GO:0006784
      label: heme A biosynthetic process
    evidence_type: IMP
    original_reference_id: PMID:12928484
    qualifier: involved_in
    review:
      summary: >-
        COX10 catalyzes the heme O-forming step that is required for heme A biosynthesis.
      action: ACCEPT
      reason: >-
        Core biological-process annotation.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            COX10 catalyzes the **first committed step of heme a biosynthesis**, transferring a **farnesyl group from farnesyl diphosphate** to the **vinyl group at C2 / pyrrole ring A of heme b (protoheme IX)** to form **heme o**
  - term:
      id: GO:0008535
      label: respiratory chain complex IV assembly
    evidence_type: IMP
    original_reference_id: PMID:14607829
    qualifier: involved_in
    review:
      summary: >-
        COX10 mutations impair Complex IV assembly because heme A is required for assembly of the
        cytochrome c oxidase catalytic core.
      action: ACCEPT
      reason: >-
        Correct downstream biological-process annotation supported by patient-cell assembly studies,
        while the direct molecular function remains heme O synthesis.
      supported_by:
        - reference_id: file:human/COX10/COX10-deep-research-falcon.md
          supporting_text: >-
            Heme A is uniquely used by **cytochrome c oxidase (Complex IV)** and is required not only for catalysis but also for proper maturation/stability of the catalytic core subunit **COX1**.
  - term:
      id: GO:0004311
      label: farnesyl-diphosphate farnesyltransferase activity
    evidence_type: TAS
    original_reference_id: PMID:8078902
    qualifier: enables
    review:
      summary: >-
        GO:0004311 is now labeled farnesyl-diphosphate farnesyltransferase activity, but it is
        still not COX10's reaction. COX10 uses farnesyl diphosphate to farnesylate heme
        b/protoheme IX, forming heme O.
      action: REMOVE
      reason: >-
        Incorrect molecular-function assignment; keep protoheme IX farnesyltransferase activity
        (GO:0008495), which is already present, as the COX10-specific activity.
core_functions:
  - description: >-
      COX10 is the mitochondrial protoheme IX farnesyltransferase/heme O synthase that catalyzes the
      first heme A biosynthetic step. By producing heme O as the precursor to heme A, COX10 is directly
      required for heme A biosynthesis and consequently for respiratory chain Complex IV assembly.
    molecular_function:
      id: GO:0008495
      label: protoheme IX farnesyltransferase activity
    directly_involved_in:
      - id: GO:0006784
        label: heme A biosynthetic process
      - id: GO:0008535
        label: respiratory chain complex IV assembly
    locations:
      - id: GO:0005743
        label: mitochondrial inner membrane
    supported_by:
      - reference_id: PMID:12928484
        supporting_text: >-
          COX10 functions in the first step of the mitochondrial heme A biosynthetic pathway, catalyzing
          the conversion of protoheme (heme B) to heme O
      - reference_id: file:human/COX10/COX10-uniprot.txt
        supporting_text: >-
          Converts protoheme IX and farnesyl diphosphate to heme O.
      - reference_id: file:human/COX10/COX10-deep-research-falcon.md
        supporting_text: >-
          **COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate).
      - reference_id: file:human/COX10/COX10-deep-research-falcon.md
        supporting_text: >-
          COX10 is an **integral mitochondrial inner membrane protein**.
references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with GO terms
    findings:
      - statement: InterPro2GO mapping infers GO terms (protoheme IX farnesyltransferase activity, heme A / heme O biosynthetic process, mitochondrial inner membrane) for COX10 from its conserved UbiA prenyltransferase / Cox10 domain signature.
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings:
      - statement: PAINT/PANTHER phylogenetic annotation transfers experimentally validated COX10 / heme O synthase functions across orthologs, supporting human COX10 annotation to protoheme IX farnesyltransferase activity and heme A biosynthetic process.
  - id: GO_REF:0000052
    title: Gene Ontology annotation based on curation of immunofluorescence data
    findings:
      - statement: Curation of Human Protein Atlas immunofluorescence images supports COX10 mitochondrial localization at IDA evidence level.
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation data to orthologs
      using Ensembl Compara
    findings:
      - statement: Ensembl Compara orthology-based transfer propagates experimentally verified heme A biosynthesis / mitochondrial inner membrane annotations from COX10 orthologs to human COX10.
  - id: GO_REF:0000117
    title: Electronic Gene Ontology annotations created by ARBA machine learning models
    findings:
      - statement: ARBA machine-learning rules predict GO terms (protoheme IX farnesyltransferase activity, heme A biosynthetic process, mitochondrial inner membrane) for COX10 from sequence and family features.
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods
    findings:
      - statement: A combined automated pipeline integrating multiple IEA methods produces high-confidence IEA annotations of COX10 to the mitochondrial inner membrane and protoheme IX farnesyltransferase activity.
  - id: PMID:12928484
    title: Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and
      account for multiple, early-onset clinical phenotypes associated with isolated COX
      deficiency.
    findings:
      - statement: Biallelic COX10 missense mutations cause isolated cytochrome c oxidase deficiency with a broad phenotypic spectrum (Leigh syndrome, hypertrophic cardiomyopathy, sensorineural deafness, anemia, tubulopathy / leukodystrophy), establishing COX10 as a major COX assembly disease gene.
        supporting_text: This study shows that mutations in this gene can cause nearly the full range of clinical phenotypes associated with early onset isolated COX deficiency.
      - statement: COX10 catalyses the first step of the mitochondrial heme A biosynthetic pathway, converting protoheme (heme B) to heme O by farnesylation of the C2 vinyl group, and patient heme A content is reduced in proportion to residual COX enzyme activity.
        supporting_text: COX10 functions in the first step of the mitochondrial heme A biosynthetic pathway, catalyzing the conversion of protoheme (heme B) to heme O via the farnesylation of a vinyl group at position C2.
      - statement: Retroviral re-expression of COX10 functionally complements patient fibroblast COX deficiency and reduced heme A content is rescued, providing direct cellular evidence that COX10 catalytic loss-of-function is the disease mechanism.
        supporting_text: expression of COX10 from a retroviral vector complements the COX deficiency in a patient with anemia and Leigh Syndrome, and in a patient with anemia, sensorineural deafness and fatal infantile hypertrophic cardiomyopathy.
  - id: PMID:14607829
    title: Cytochrome c oxidase subassemblies in fibroblast cultures from patients carrying
      mutations in COX10, SCO1, or SURF1.
    findings:
      - statement: COX10-deficient fibroblasts accumulate early MTCO1-only Complex IV subassemblies and fail to form the MTCO1·COX4·COX5A intermediate, establishing that heme A incorporation into MTCO1 must occur before MTCO1 associates with COX4 and COX5A.
        supporting_text: The MTCO1.COX4.COX5A subassembly was not detected in COX10-deficient cells, which suggests that heme A incorporation into MTCO1 occurs prior to association of MTCO1 with COX4 and COX5A.
      - statement: Comparison of COX10, SCO1 and SURF1 mutant fibroblasts maps three distinct stalling points of human CIV assembly, placing COX10-dependent MTCO1 hemylation upstream of Cu(A) installation (SCO1) and of MTCO2 incorporation (SURF1).
        supporting_text: SCO1-deficient cells contained accumulated levels of the MTCO1.COX4.COX5A subassembly, suggesting that MTCO2 associates with the MTCO1.COX4.COX5A subassembly after the Cu(A) center of MTCO2 is formed.
  - id: PMID:34800366
    title: Quantitative high-confidence human mitochondrial proteome and its dynamics in
      cellular context.
    findings:
      - statement: Quantitative mass-spectrometry-based mitochondrial proteomics confirms COX10 as a high-confidence mitochondrial protein and provides HTP evidence for its mitochondrion / inner membrane localization.
        supporting_text: Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
  - id: PMID:8078902
    title: Isolation of a human cDNA for heme A:farnesyltransferase by functional
      complementation of a yeast cox10 mutant.
    findings:
      - statement: Cloned the human COX10 cDNA encoding a 443-aa heme A:farnesyltransferase by functional complementation of a yeast cox10-null mutant, providing the original molecular identification of human COX10.
        supporting_text: We have cloned the human homolog of the Saccharomyces cerevisiae COX10 gene by functional complementation of a yeast cox10 null mutant.
      - statement: Demonstrates strong sequence and functional homology between human COX10 and the yeast and bacterial farnesyltransferases (heme O synthases), justifying transfer of yeast/bacterial Cox10 function to the human ortholog.
        supporting_text: The 2.8-kb cDNA encoding the human heme A:farnesyltransferase codes for a 443-aa protein with high homology to the yeast and bacterial farnesylases.
  - id: Reactome:R-HSA-189451
    title: Heme biosynthesis
    findings:
      - statement: Reactome curates COX10 as a participant in the broad heme biosynthesis pathway; the more specific heme O / heme A biosynthetic-process annotations and COX10-specific Reactome reaction better capture its enzymatic role.
  - id: Reactome:R-HSA-2995330
    title: COX10 transforms heme to heme O
    findings:
      - statement: Reactome's reaction "COX10 transforms heme to heme O" describes the COX10-catalysed first step of heme A biosynthesis at the mitochondrial inner membrane, supporting the protoheme IX farnesyltransferase activity (GO:0008495) annotation at TAS evidence level.
  - id: file:human/COX10/COX10-deep-research-falcon.md
    title: Falcon deep research report on COX10
    findings:
      - statement: >-
          COX10 catalyzes the first committed step of heme A biosynthesis, transferring a farnesyl
          group from farnesyl diphosphate to the C2 vinyl group (pyrrole ring A) of heme b/protoheme
          IX to form heme O.
        supporting_text: >-
          **COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate).
        reference_section_type: RESULTS
      - statement: >-
          The proposed catalytic mechanism involves Mg2+-assisted ionization of farnesyl diphosphate,
          forming a farnesyl cation that is attacked by the heme vinyl group, with pyrophosphate release.
        supporting_text: >-
          the reaction is proposed to involve **Mg2+-assisted ionization of farnesyl diphosphate** to form a stabilized **farnesyl cation**, followed by **attack of the heme vinyl** to form the C–C bond; **pyrophosphate release** is implied by the diphosphate ionization step and the described donor chemistry.
        reference_section_type: DISCUSSION
      - statement: >-
          Heme A biosynthesis is a two-step mitochondrial pathway: COX10 converts heme b to heme o,
          then COX15 converts heme o to heme a.
        supporting_text: >-
          Heme A is produced by a two-step pathway in mitochondria:
          1) **COX10 (heme o synthase): heme b → heme o** (prenylation), and
          2) **COX15 (heme a synthase): heme o → heme a**
        reference_section_type: RESULTS
      - statement: >-
          Heme A is used exclusively by cytochrome c oxidase (Complex IV) and is required for
          catalytic function as well as proper maturation/stability of the catalytic core subunit COX1.
        supporting_text: >-
          Heme A is uniquely used by **cytochrome c oxidase (Complex IV)** and is required not only for catalysis but also for proper maturation/stability of the catalytic core subunit **COX1**.
        reference_section_type: RESULTS
      - statement: >-
          COX10 is an integral mitochondrial inner membrane protein.
        supporting_text: >-
          COX10 is an **integral mitochondrial inner membrane protein**.
        reference_section_type: RESULTS
      - statement: >-
          COX10 is a ~46 kDa polytopic inner membrane enzyme with a predicted 8-9 transmembrane helices
          and a matrix-facing catalytic site; it assembles into homo-oligomeric complexes of ~300 kDa.
        supporting_text: >-
          - **~46 kDa**, evolutionarily conserved,
          - predicted **8–9 transmembrane helices**, with the **catalytic site facing the matrix**, and
          - assembling into **homo-oligomeric complexes (~300 kDa)**.
        reference_section_type: RESULTS
      - statement: >-
          Human COX10 is associated with COX15 and copper/metallochaperone factors (COX11, SCO1, SCO2,
          COA3, COX16, PET191, COX19) and was detected in the SURF1 interactome, integrating heme A
          biosynthesis with Complex IV assembly.
        supporting_text: >-
          human COX10 is trapped together with COX15 and multiple copper/metallochaperone factors (e.g., COX11, SCO1/2, COA3, COX16, PET191, COX19), linking heme A biosynthesis with copper delivery modules and early assembly intermediates. COX10 silencing impacted levels of PET191/COX19 and impaired formation of early metallochaperone complexes, supporting a systems-level role in complex IV biogenesis beyond a standalone enzymatic step.
        reference_section_type: RESULTS
      - statement: >-
          COX10 oligomerization depends on newly synthesized COX1 and early COX1 assembly intermediates,
          coupling heme A production to the assembly state of Complex IV.
        supporting_text: >-
          mitochondrial heme reviews describe COX10 oligomerization as depending on newly synthesized **COX1** and early COX1 assembly intermediates, consistent with heme A production being tuned to the assembly state of complex IV.
        reference_section_type: DISCUSSION
      - statement: >-
          Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, causing Complex
          IV deficiency and Leigh(-like) syndromes.
        supporting_text: >-
          Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, leading to **complex IV deficiency**; COX10 mutations are repeatedly discussed as causes of severe mitochondrial disease presentations including **Leigh(-like) syndromes** and other complex IV deficiency phenotypes.
        reference_section_type: DISCUSSION
      - statement: >-
          COX10 belongs to the UbiA intramembrane aromatic prenyltransferase family. Orthology between
          human COX10 and yeast Cox10 was established by functional complementation.
        supporting_text: >-
          Human **COX10** (UniProt **Q12887**) corresponds to **protoheme IX farnesyltransferase, mitochondrial**, also called **heme O synthase**; it belongs to the **UbiA intramembrane aromatic prenyltransferase family** that catalyzes membrane-embedded prenyl transfer reactions. Orthology between human COX10 and yeast Cox10 was established by functional complementation.
        reference_section_type: RESULTS
      - statement: >-
          A 2024 yeast complementation assay of 25 human COX10 variants found 11/25 supported ~50% or
          more of reference cytochrome c oxidase activity; ClinVar had 102 COX10 variants as of Jun 2024,
          with ~75% classified as variants of uncertain significance.
        supporting_text: >-
          **ClinVar listed 102 COX10 variants** as of **17 Jun 2024**, with **nearly three-quarters** categorized as **variants of uncertain significance (VUS)**. (voges2024phenotypicassessmentof pages 1-2)
          - The authors tested **25 human COX10 variants**; **11/25** supported **~50% or more** of reference cytochrome c oxidase activity and also grew robustly on nonfermentable medium.
        reference_section_type: RESULTS
      - statement: >-
          A small assembly factor COA2 stabilizes the COX10 complex; COX10 and COX15 function together
          for heme A synthesis.
        supporting_text: >-
          COX10 and COX15 are described as interacting/working together for heme A synthesis, and a small assembly factor **COA2** is described as stabilizing the COX10 complex.
        reference_section_type: RESULTS

suggested_questions:
  - question: Are COX10 and COX15 organized as a single physical heme A biosynthesis super-complex that channels heme O without release into the bulk inner membrane lipid bilayer?
    experts:
      - Khalimonchuk O
      - Shoubridge EA
  - question: How does coupling of COX10 oligomerization to newly synthesized COX1 ensure that heme O is produced on-demand, and what disassembles COX10 oligomers when CIV assembly stalls?
    experts:
      - Shoubridge EA
      - Tzagoloff A
  - question: For ClinVar COX10 variants of uncertain significance, what fraction are simple loss-of-function vs separation-of-function (e.g. preserved farnesyltransferase activity but disrupted COX1 / COX15 interactions)?
    experts:
      - Voges N
      - Antonicka H
  - question: Is excess heme O an alternative cofactor under heme A synthase deficiency, and does heme O accumulation in COX15-deficient cells contribute to specific pathology beyond CIV loss?
    experts:
      - Khalimonchuk O

suggested_experiments:
  - hypothesis: COX10 and COX15 form an obligate heme A synthesis super-complex with COX1 that channels heme O between active sites.
    description: Apply native MS / crosslinking-MS to immunopurified COX10 and COX15 complexes from human cells; complement with proximity labeling (BioID/TurboID) of active vs catalytically inactive COX10 and COX15 to map the heme-channeling interface; quantify free heme O / heme A pools by LC-MS in the same cells.
    experiment_type: native MS and proximity labeling of heme A biosynthetic complexes
  - hypothesis: COX10 oligomerization is gated by newly synthesized MT-CO1; uncoupling MT-CO1 translation from heme O production triggers COX10 disassembly and degradation.
    description: Use puromycin-pulse, doxycycline-controlled MT-CO1 translation, and COA3/COX14 depletion in human cells; track COX10 oligomeric state (BN-PAGE, sucrose gradients) and turnover (cycloheximide chase / SILAC).
    experiment_type: translational coupling and oligomer dynamics assay
  - hypothesis: A subset of ClinVar VUS COX10 alleles are separation-of-function variants that preserve farnesyltransferase activity in vitro but fail to support CIV assembly in vivo.
    description: Reconstitute recombinant COX10 variants in liposomes / nanodiscs and measure protoheme IX farnesyltransferase kinetics; compare against complementation rescue of COX10-null human cells (CIV activity, BN-PAGE, mitochondrial respirometry) for the same panel of variants.
    experiment_type: paired in-vitro enzymology and human-cell complementation of ClinVar VUS

Gene Description

Existing Annotations Review

Core Functions

COX10 is the mitochondrial protoheme IX farnesyltransferase/heme O synthase that catalyzes the first heme A biosynthetic step. By producing heme O as the precursor to heme A, COX10 is directly required for heme A biosynthesis and consequently for respiratory chain Complex IV assembly.

References

Suggested Questions for Experts

Suggested Experiments

Deep Research

Falcon

Research report: Human COX10 (UniProt Q12887) – functional annotation

0) Mandatory target verification (gene/protein identity)

1) Key concepts and definitions (current understanding)

1.1 COX10 biochemical function (reaction, substrates, products)

1.2 Pathway context: heme A biosynthesis and Complex IV biogenesis

2) Cellular localization, membrane topology, and molecular organization

2.1 Subcellular compartment

2.2 Topology and oligomeric state (best current model)

3) Recent developments and latest research (prioritized 2023–2024)

3.1 Integration with Complex IV assembly modules (2023 review synthesis)

3.2 Functional interpretation of human COX10 variants at scale (2024)

3.3 Yeast as an expert-endorsed platform for COX deficiency variant interpretation (2024 review)

4) Functional role in protein networks: interaction partners and assembly logic

4.1 COX10–COX15 functional coupling and stabilization

4.2 Human cell evidence for association with metallochaperone assemblies (authoritative primary research)

5) Disease relevance, applications, and real-world implementations

5.1 Disease mechanism (mitochondrial respiratory chain / Leigh spectrum)

5.2 Current applications

6) Data-driven summary (selected statistics and experimentally grounded statements)

7) Limitations and open questions (expert synthesis)

Key URLs (most relevant; with publication month/year)

Artifacts

Citations

📄 View Raw YAML